Influence of the medicare reimbursement system on ICD implantation

Cardiac Electrophysiology Review

Volumn 5, Issue 1, 2001, Pages 134-136

  Hammill, S C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; FOLLOW UP; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HEART ARRHYTHMIA; HUMAN; MEDICARE; REIMBURSEMENT; TREATMENT INDICATION;

EID: 0034882194     PISSN: 13852264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. The cost effectiveness of autonomic implantable cardiac defibrillators: Results from MADIT
2. Impact of managed care
3. Unsustained ventricular tachycardia: To treat or not to treat
4. Estimating the proportion of post-myocardial infarction patients who may benefit from prophylactic implantable defibrillator placement from analysis of the CAST registry
5. FDA speeds approval of wider use of heart attack device
6. Impact of the multicenter automatic defibrillator implantation trial on implantable cardioverter defibrillator indication trends
7. Medical devices: Factors adversely affecting innovation
8. Economic impact of advancing implantable cardioverter defibrillator technologies: Decreased monetary costs and earlier hospital discharge